The reason for the long wait is unclear, but it may be telling that the company that initially developed PT-141 (King Pharmaceuticals) was acquired in 2010 by Pfizer, which famously manufactures Viagra and had a vested interest in keeping PT-141 off the shelves until after Viagras patent expired in 2020
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context by identifying your genetic predispositions in key GLP-1 signaling pathwaysincluding variants in GIPR and MC4R, and FTO genes that influence appetite regulation and metabolic response
"What's in a color
The mean age of the enrolled participants was 53.8 (SD = 9)
Traditionally GLP-1(9-36) was considered inactive, however more recent studies indicate that GLP-1(9-36) can contribute to inhibiting glucagon secretion by inhibiting voltage-gated calcium channels through a GPCR mechanism, an effect which reduces the number of glucagon containing vesicles that are available for exocytosis, thereby contributing the the decrease in glucagon secretion (Figure 1)(Zheng et al, 2024)
Injectable GLP-1 agonists give your body that stronger, longer-lasting signal to: Reduce appetite Manage blood glucose Support gradual, sustainable weight loss Who is GLP-1 Recommended For